
Elizabeth Plimack
Deputy Director, Fox Chase Cancer Center · Temple University Hospital
Credentials: · · · · ·
History
PresentFox Chase Cancer Center · Temple University Hospital
PresentGenitourinary Clinical Research · Temple University Hospital
Present2018 BCAN Think Tank Department · Temple University Hospital
- 2002–2005
Internal Medicine
- 1998–2002
Research
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · 4,745 citations
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2018 · 3,758 citations
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2019 · 2,745 citations

56 papers

42 papers · 1 as a fellow

36 papers

33 papers

32 papers

30 papers

29 papers

28 papers
Clinical trials
- 2012–2019
Principal investigator · Terminated · Phase 2
Fox Chase Cancer Center
- 2010–2014
Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
Principal investigator · Completed · Phase 1
Fox Chase Cancer Center
- 2009–2013
Dose Dense MVAC for Muscle Invasive Bladder Cancer
Principal investigator · Completed · Phase 2
Fox Chase Cancer Center
- 2025–2029
Site PI · Recruiting · Phase 2
Matthew Galsky


